Masitinib is an oral inhibitor of tyrosine kinases, enzymes important for immune cells thought to drive ALS inflammation and ...

Yunu, creator of the leading clinical trial imaging software platform, announced a strategic partnership with IgniteData to offer sponsor customers Yunu-managed workflows that create connectivity ...

Shakthi Kumar, EDETEK, Inc.'s Chief Strategy and Business Officer, explores the company's launch of R&D Cloud.

Galderma (SWX:GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset and the long-lasting duration of ...

Department of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing, China ...

Yunu, a leading provider of clinical trial imaging workflow and data management solutions, is pleased to announce its partnership with WCG, a global leader in clinical trial solutions, in support of ...

To report SUSPECTED ADVERSE REACTIONS, contact Zevra Therapeutics, Inc. at toll-free phone 1-844-600-2237 or FDA at 1‐800-FDA-1088 or .

Rush is developing an innovative data platform to improve the health of Chicagoans. Funded by a $7.5 million grant from the Searle Funds at the Chicago Community Trust, the project will fortify Rush’s ...

Girish N. Nadkarni, MD, MPH, CPH, an accomplished physician-scientist driving advances in artificial intelligence, has been ...

By analyzing almost 10,000 pregnancies, researchers discovered previously unidentified combinations of risk factors linked to serious negative pregnancy outcomes, finding that there may be up to a ...

Atai Life Sciences N.V. reported positive top-line phase 2a results of BPL-003 in treating Alcohol Use Disorder patients.

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...